12 postdoc-in-distributed-systems-and-controls PhD scholarships at Heidelberg University
Sort by
Refine Your Search
-
Listed
-
Field
-
PhD position (f/m/d) “How to regulate the duration of mitosis and control cell fate decisions” Centre for Molecular Biology (ZMBH) Heidelberg University, Germany We are seeking highly motivated PhD
-
data integration, cancer systems biology, and single-cell analysis, with strong links to clinical and translational oncology. Our work is based in the dynamic research environment of Heidelberg
-
project “Single cell multi-omics to unravel niche plasticity in AML therapy resistance“ we are looking for a PhD student. The project is part of the SFB/CRC 1709 “Cellular Plasticity in Myeloid Malignancies
-
“Mitochondrial RNA modification- driven metabolic plasticity in leukemic stem cells and drug resistance“ we are looking for a PhD student. The project is is part of the SFB/CRC 1709 “Cellular Plasticity in Myeloid
-
xenograft (PDX) models. To this end, the candidate will have direct access to cutting-edge mass spectrometry and advanced bioinformatics infrastructure. The project is part of the collaborative research
-
“Multi-modal proteomics to understand and overcome niche-related adaptive drug-resistance mechanisms in FLT3-mutated AML“ we are looking for a PhD student. The project is is part of the SFB/CRC 1709
-
“Functional and molecular characterization of AI-based morphological predictors of therapy response in Acute Myeloid Leukemia“ we are looking for a PhD student. The project is is part of the SFB/CRC 1709
-
The research group of Prof. Dr. Michael Mastalerz at the Institute of Organic Chemistry, Heidelberg University is seeking the following temporary position from October 15th 2025 or later: PhD
-
Stellenanzeige teilen wanted for the next possible date at the Department of Pediatric Oncology, Hematology and Immunology . Osteosarcoma (OS) is an aggressive bone cancer mainly affecting children and young
-
against cardiac diseases. It is based on extensive preliminary work by our working group, which has demonstrated therapeutic effects of the synthetic peptide in chronic and acute heart failure animal models